Clinical decision-making in the face of scientific uncertainty: Hormone replacement therapy as an example

Journal of Family Practice

Volumn 42, Issue 2, 1996, Pages 147-151

  Mort, Elizabeth A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Clinical decision making; hormone replacement therapy; patient satisfaction; physicians' practice patterns; primary health care

Indexed keywords

CONFERENCE PAPER; HORMONE SUBSTITUTION; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PATIENT SATISFACTION; PRESCRIPTION; QUALITY OF LIFE; TREATMENT PLANNING;

DECISION MAKING; DECISION SUPPORT TECHNIQUES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS;

EID: 0030056301     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Chassin MR, Kosecoff J, Park RF., et al. Variation in the use of medical and surgical services by the Medicare population. N Engl J Med 1986; 314:285-90.
2. Hemminki E, Kennedy DL, Baum C, McKinlay S. Prescribing patterns of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health 1988; 78:1478-81.
3. Greendale GA, Carlson KJ, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. J Gen Intern Med 1990; 5:464-9.
4. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med 1989; 149:133-6.
5. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117:1016-37.
6. Colditz GA. Hankinson SE, Hunter DJ, Willit WW, Manson JE, Stampfer MJ, et al. The use of estrogen and progestins and their risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332:1589-93.
7. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274.137-42.
8. Consensus development conference: prophylaxis and treatment of osteoporosis Am J Med 1991; 90:107-10.
9. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ Epidemiology of osteoporotic fractures Epidemiol Rev 1985; 7:178-208.
10. Rich-Edwards JW, Manson JF., Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 26:1758-66
11. Holmes MM, Rovner DR, Rothert ML, Elstein AS, Holzman GB, Hoppe RB, et al. Women's and physicians' utilities for health outcomes in ehtrogen replacement therapy. J Gen Intern Med 1987; 2:178-82.
12. Wallace WA, Price VH, Elliot CA, MacPherson MBA, Scott BW. Hormone replacement therapy acceptability to post-menopausal women with a risk factor for osteoporosis. J Royal Soc Med 1990; 83:699-701.
13. Siminoff LA, Petting JH, AbclofF MD. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 1989; 7:1192.
14. Eisenberg JM. Sociologic influences on decision-making by clinicians. Ann Intern Med 1979, 90.957-64.
15. Wennberg JE, Barnes BA, Zubkolf M. Professional uncertainty and the problem of supplier induced demand. Soc Sci Med 1982, 16: 811-24.
16. Rosenberg L. Hormone replacement therapy: the need for reconsideration. Am J Public Health 1993; 83:1670-3.
17. Livingston WW, Healy JM, Jordan HS, Warner CK, Zazzali JL. Assessing the needs of women and clinicians for the management of menopause in an HMO. J Gen Intern Med 1994; 9:385-9.
18. Wilkes HC, Meade TW. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ 1991; 302:1317-20.
19. Mulley AG. Assessing patients' utilities: can the ends justify the means? Med Care 1989; 27:S269-81.
20. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57:109-12.
21. Mulley AG. Methodologic issues in applying effectiveness and outcomes research to clinical practice In: Heithoff KA, Lohr KN, eds. Effectiveness and outcomes in health care Washington, DC: National Academy Press, 1990:179-89.
22. Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychosocial outcomes, of different treatment poticies in women with early breast cancer outside a clinical trial. BMJ 1990; 301:575-80.
23. Morris J, Royle GT. Offering patients a choice of surgery for early breast cancer: a reduction in anxiety and depression in patients and their husbands. Soc Sci Med 1988; 26:583-5.
24. Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care: effects on patient outcomes. Ann Intern Med 1985; 102: 520-8.
25. Greenfield S, Kaplan SH, Ware JE, Yano EM, Frank HJ. Patients' participation in medical care efforts in blood sugar control and quality of life in diabetics. J Gen Med 1988; 3:448-7.
26. Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med 1980; 92:832-6.
27. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy: decision making and information-seeking preferences among medical patients J Gen Intern Med 1989; 4:23-30.
28. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA 1992, 267.2221-6.
29. Fallowfield LJ, Hall A, Maguire P, et al. A question of choice: result of a prospective 3-year follow-up study of women with breast cancer. Breast 1994; 3:302-8.
30. Nayfield SG, Bongiovanni GC, Alciati MH, Fischer RA, Bergner L. Statutory requirements for disclosure of breast cancer treatment alternatives. J Natl Cancer Inst 1994; 86:1202-8.
31. Starfield B. Primary care concept, evaluation, and policy. New York, NY: Oxford University Press, 1993.
32. Kasper JF, Mulley AG, Wennberg JE. Developing shared decision-making programs to improve the quality of health care. Qual Rev Bull 1992; 18:183-90.
33. Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign proslatic hyperplasia. Med Care 1995; 33:771-82.
34. Wagner EH, Barrett P, Barry MJ, Barlow W, Fowler FJ. The effect of a shared decisionmaking program on rates of surgery for benign prostatic hyperplasia pilot results Med Care 1995; 33-765-70.
35. Randall T. Producers of videodisc programs strive to expand patient's role in medical decision-making process. JAMA 1993, 270: 160-2.
36. Gustafson DH, Wise M, McTavish FM, Taylor JO, Wolberg W, Stewart J, et al. Development and pilot evaluation of a computer-based support system for women with breast cancer J Psychosoc Oncol 1993; 11:69-93.
37. McTavish FM, Gustafson DH, Owens BH, Wise M, Taylor JO, Apantaku FM, et al. CHESS: an interactive computer system for women with breast cancer piloted with an under-served population. J Am Med Information Assn 1994; (suppl):599.
38. Levine MN, Gafni A, Markham B, MacFarlane D. A bedside instrument to elicit patients' preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 1992; 117:53-8.
39. Kemper DW. Healthwise handbook, a self-care manual for you. 12th ed. Boise, Idaho: Healthwise, Inc, 1995.